DekaBank Deutsche Girozentrale’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.35M | Hold |
12,211
| – | – | 0.01% | 628 |
|
|
2026
Q1 | $3.42M | Hold |
12,211
| – | – | 0.01% | 628 |
|
|
2025
Q4 | $3.65M | Hold |
12,211
| – | – | 0.01% | 647 |
|
|
2025
Q3 | $3.28M | Hold |
12,211
| – | – | 0.01% | 663 |
|
|
2025
Q2 | $2.98M | Sell |
12,211
-124
| -1% | -$29.3K | 0.01% | 670 |
|
|
2025
Q1 | $2.97M | Buy |
12,335
+124
| +1% | +$37.3K | 0.01% | 662 |
|
|
2024
Q4 | $3.98M | Hold |
12,211
| – | – | 0.01% | 623 |
|
|
2024
Q3 | $4.03M | Sell |
12,211
-3,376
| -22% | -$1.07M | 0.01% | 627 |
|
|
2024
Q2 | $4.23M | Buy |
15,587
+3,252
| +26% | +$946K | 0.01% | 617 |
|
|
2024
Q1 | $4.3M | Sell |
12,335
-914
| -7% | -$301K | 0.01% | 607 |
|
|
2023
Q4 | $4.25M | Sell |
13,249
-92
| -0.7% | -$28.8K | 0.01% | 615 |
|
|
2023
Q3 | $4.74M | Buy |
13,341
+4,325
| +48% | +$1.67M | 0.01% | 555 |
|
|
2023
Q2 | $3.38M | Sell |
9,016
-559
| -6% | -$227K | 0.01% | 640 |
|
|
2023
Q1 | $4.48M | Sell |
9,575
-379
| -4% | -$177K | 0.01% | 561 |
|
|
2022
Q4 | $4.21M | Buy |
9,954
+1,976
| +25% | +$798K | 0.01% | 578 |
|
|
2022
Q3 | $3.31M | Buy |
7,978
+256
| +3% | +$128K | 0.01% | 601 |
|
|
2022
Q2 | $3.76M | Sell |
7,722
-1,012
| -12% | -$527K | 0.01% | 591 |
|
|
2022
Q1 | $5.06M | Sell |
8,734
-43
| -0.5% | -$25.9K | 0.01% | 561 |
|
|
2021
Q4 | $6.62M | Sell |
8,777
-465
| -5% | -$348K | 0.02% | 505 |
|
|
2021
Q3 | $6.91M | Buy |
9,242
+32
| +0.3% | +$24K | 0.02% | 461 |
|
|
2021
Q2 | $5.84M | Sell |
9,210
-120
| -1% | -$73K | 0.02% | 488 |
|
|
2021
Q1 | $5.24M | Buy |
9,330
+482
| +5% | +$285K | 0.02% | 472 |
|
|
2020
Q4 | $5.07M | Sell |
8,848
-3,275
| -27% | -$1.87M | 0.02% | 450 |
|
|
2020
Q3 | $6.14M | Buy |
12,123
+587
| +5% | +$297K | 0.03% | 359 |
|
|
2020
Q2 | $5.03M | Buy |
11,536
+1,914
| +20% | +$845K | 0.03% | 319 |
|
|
2020
Q1 | $3.31M | Sell |
9,622
-639
| -6% | -$235K | 0.03% | 332 |
|
|
2019
Q4 | $3.75M | Buy |
10,261
+1,088
| +12% | +$384K | 0.02% | 384 |
|
|
2019
Q3 | $3.08M | Sell |
9,173
-720
| -7% | -$235K | 0.02% | 444 |
|
|
2019
Q2 | $3.05M | Buy |
9,893
+2,043
| +26% | +$612K | 0.02% | 533 |
|
|
2019
Q1 | $2.56M | Sell |
7,850
-300
| -4% | -$81K | 0.02% | 553 |
|
|
2018
Q4 | $1.88M | Buy |
8,150
+300
| +4% | +$80.5K | 0.01% | 549 |
|
|
2018
Q3 | $2.56M | Hold |
7,850
| – | – | 0.02% | 566 |
|
|
2018
Q2 | $2.27M | Sell |
7,850
-600
| -7% | -$166K | 0.01% | 554 |
|
|
2018
Q1 | $2.11M | Sell |
8,450
-1,150
| -12% | -$293K | 0.01% | 560 |
|
|
2017
Q4 | $2.06M | Hold |
9,600
| – | – | 0.02% | 538 |
|
|
2017
Q3 | $2.06M | Hold |
9,600
| – | – | 0.02% | 546 |
|
|
2017
Q2 | $2.16M | Hold |
9,600
| – | – | 0.02% | 531 |
|
|
2017
Q1 | $1.92M | Buy |
+9,600
| New | +$1.85M | 0.02% | 493 |
|
Other funds holding BIO
AI
DekaBank Deutsche Girozentrale's BIO Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 12,211 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #628.
DekaBank Deutsche Girozentrale first reported a position in BIO in Q1 2017 and has held it in 38 quarters since. The position peaked at $6.91M in Q3 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- DekaBank Deutsche Girozentrale held 12,211 shares of Bio-Rad Laboratories Class A worth $3.35M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
- Bio-Rad Laboratories Class A made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #628 holding.
- DekaBank Deutsche Girozentrale first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and has held it in 38 quarters since.
- DekaBank Deutsche Girozentrale's Bio-Rad Laboratories Class A position peaked at $6.91M in Q3 2021.
- 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.